Zhejiang Orient Gene Biotech Co., Ltd.
SHH: 688298.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Xiaoliang Fang
- Employees
- 2,231
- Headquarters
- Huzhou, China
- IPO year
- 2020
- Market cap
- CN¥4.8B
- Website
- https://www.orientgene.com
Loading 688298…
Loading profile data…Frequently asked questions about 688298
What does Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) do?
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells colloidal gold tests, urinalysis strips, raw materials, instruments, and molecular diagnosis products primarily in China. Its products include genetic diagnosis products; colloidal gold rapid diagnostic tests for drugs of abuse, infectious diseases, fertility, ca...
Where does 688298.SS trade?
Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) trades on the Shanghai Stock Exchange.
What sector is 688298.SS in?
Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Zhejiang Orient Gene Biotech Co., Ltd.?
Xiaoliang Fang is the chief executive officer of Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS).
Where is Zhejiang Orient Gene Biotech Co., Ltd. headquartered?
Zhejiang Orient Gene Biotech Co., Ltd. is headquartered in China.
Does 688298.SS pay a dividend?
Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 688298.SS go public?
Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) completed its initial public offering in 2020.